Immupharma (IMM)


ImmuPharma agrees £50 financing

ImmuPharma - the specialist drug discovery and development company - has secured a £50m, five -year equity financing facility with Darwin Strategi to fund ImmuPharma's late stage Lupuzor compound.

ImmuPharma says the £50m facility allows it to complete the last development stage, phase III - of its blockbuster Lupuzor compound while continuing discussions with major pharmaceutical companies for a potential corporate deal.